HR-3419-119
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsored by David Valadao (R-CA)
What it does
This bill would reauthorize through fiscal year 2030 two existing federal grant programs: one supporting telehealth networks and one supporting telehealth resource centers. Both programs are administered by the Office for the Advancement of Telehealth within the Health Resources and Services Administration (HRSA). The grants fund health care providers and related organizations to build telehealth networks that expand access to and improve the quality of health care in rural and medically underserved areas.
Who benefits
Patients in rural and medically underserved communities who currently lack convenient access to in-person specialists or primary care providers. Health care providers in those areas who receive grant funding to build or expand telehealth infrastructure. Telehealth technology vendors and contractors who supply equipment and services to grant recipients. Community health centers and federally qualified health centers that frequently serve underserved populations. Elderly and disabled patients for whom travel to in-person appointments is a significant barrier.
Who is hurt
Taxpayers who bear the cost of the grant funding. In-person health care providers in or near underserved areas who may face reduced patient volume if telehealth alternatives expand. Grant applicants who are not selected for funding, as the program is competitive. Potentially, patients in non-rural areas who do not qualify for these targeted programs and may not see comparable federal support for telehealth access.
Supporters argue
Supporters argue that rural Americans face a persistent shortage of health care providers — the Health Resources and Services Administration designates over 8,000 Health Professional Shortage Areas nationwide — and that telehealth networks have demonstrated measurable success in bridging that gap. They contend that allowing these grant programs to lapse would disrupt existing telehealth infrastructure that rural and underserved communities have come to rely on, and that a five-year reauthorization through 2030 provides the funding stability necessary for long-term network development.
Opponents argue
Opponents argue that the private telehealth market has expanded dramatically since these programs were first created, with commercial platforms now widely available, and that continued federal subsidies may crowd out private investment in rural telehealth rather than complement it. They contend that reauthorizing the programs without a rigorous evaluation of their outcomes — such as measurable improvements in patient health metrics or cost-effectiveness data — represents an extension of spending that may not be justified by demonstrated results.